Clinical Trial Update: Post COVID-19 Condition

View source ↗

Summary

An ongoing clinical trial sponsored by Euresist Network GEIE is investigating post-COVID-19 condition (long COVID). The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Euresist Network GEIE | Conditions: COVID-19 | Status: RECRUITING